For many patients with type 1 diabetes mellitus and selected patients with type 2 diabetes mellitus, a successful pancreas transplant is the only definitive long-term treatment that both restores euglycaemia without the risk of severe hypoglycaemia and prevents, halts or reverses secondary complications. These benefits come at the cost of major surgery and lifelong immunosuppression. Nevertheless, pancreas transplants are safe and effective, with patient survival rates currently >95% at 1 year and >88% at 5 years; graft survival rates are almost 85% at 1 year and >60% at 5 years. The estimated half-life of a pancreas graft is now 7–14 years. The improvements in graft survival are attributable to considerable reductions in technical failures and in immunologic graft losses. Pancreas recipients have reduced mortality compared with waiting candidates or patients with diabetes mellitus who undergo a kidney transplant alone. Pancreas transplants should be more frequently offered to nonuraemic patients with brittle diabetes mellitus to prevent the development of secondary diabetic complications and to avoid the need for a kidney transplant. Although the results of islet transplantation have also improved, islet recipients rarely maintain long-term insulin independence despite the use of multiple organ donor pancreases. Pancreas transplants and islet transplants should be considered complementary, not mutually exclusive, procedures that are chosen on the basis of the individual patient's surgical risk.
Pancreas transplants in appropriately selected patients with diabetes mellitus have evolved into a safe and very effective treatment to restore euglycaemia without the risk of severe hypoglycaemia
Pancreas transplants are an option for many patients with type 1 diabetes mellitus, selected patients with type 2 diabetes mellitus and selected patients with surgery-induced diabetes mellitus
A successful pancreas transplant can prevent, halt or reverse the development or progression of secondary complications of diabetes mellitus
Outcomes at 1-year after transplant have considerably improved, with rates of patient survival now at >95% and graft survival rates (insulin independence) at almost 85%
A future shift to offering pancreas transplants to patients with diabetes mellitus without uraemia (rather than transplants for those with uraemia or posturaemia) seems to be desirable
Transplants of the pancreas or islets are complementary procedures chosen on the basis of surgical risk; until islet transplants achieve long-term insulin independence, pancreas transplant remains the treatment of choice
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Die Diabetologie Open Access 13 July 2022
Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives
Reviews in Endocrine and Metabolic Disorders Open Access 23 March 2021
Stem Cell Research & Therapy Open Access 08 July 2020
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
American Diabetes Association. Diabetes statistics [online], (2013).
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977–986 (1993).
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med. 342, 381–389 (2000).
Patterson, C. C. et al. Early mortality in EURODIAB population-based cohorts of type 1 diabetes diagnosed in childhood since 1989. Diabetologia 50, 2439–2442 (2007).
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group. Long-term effect of diabetes and its treatment on cognitive function. N. Engl. J. Med. 356, 1842–1852 (2007).
Skrivarhaug, T. et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia 49, 298–305 (2006).
Sutherland, D. E. R. & Gruessner, R. W. G. Transplantation of the Pancreas 39–68 (Springer-Verlag, 2004).
Sutherland, D. E. R. et al. Twin-to-twin pancreas transplantation: reversal and reenactment of the pathogenesis of type 1 diabetes. Trans. Assoc. Am. Physicians 97, 80–87 (1984).
Kelly, W. D., Lillehei, R. C., Merkel, F. K., Idezuki, Y. & Goetz, F. C. Allotransplantation of the pancreas and duodenum along with the kidney in diabetic nephropathy. Surgery 61, 827–835 (1967).
Gruessner, A. C. & Gruessner, R. W. G. Pancreas transplant outcomes for United States and non United States cases as reported to the United Network for Organ Sharing and the International Pancreas Transplant Registry as of December 2011. Clin. Transpl. 23–40 (2012).
Gruessner, A. C. et al. Pancreas after kidney transplants in posturemic patients with type 1 diabetes mellitus. J. Am. Soc. Nephrol. 12, 2490–2499 (2001).
Gruessner, R. W. G., Sutherland, D. E. R., Kandaswamy, R. & Gruessner, A. C. Over 500 solitary pancreas transplants in nonuremic patients with brittle diabetes mellitus. Transplantation 85, 42–47 (2008).
Gruessner, R. W. G., Sutherland, D. E. R., Drangstveit, M. B., Kandaswamy, R. & Gruessner, A. C. Pancreas allotransplants in patients with a previous total pancreatectomy for chronic pancreatitis. J. Am. Coll. Surg. 206, 458–465 (2008).
Gruessner, R. W. G. in Transplantation of the Pancreas Ch. 8.2.2 (eds Gruessner, R. W. G. & Sutherland, D. E. R) 150–178 (Springer-Verlag, 2004).
Gruessner, R. W. G. & Sutherland, D. E. R. in Solid Organ Transplant Rejection: Mechanisms, Pathology and Diagnosis Ch. 19 (eds Solez, K., Racusen, L. C. & Billingham, M. E) 455–499 (Marcel Dekker, Inc., 1996).
Gruessner, A. C. & Sutherland, D. E. R. Pancreas transplant outcomes for United States (US) and non-US cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR) as of May 2003. Clin. Transpl. 21–51 (2003).
Philosophe, B. et al. Superiority of portal venous drainage over systemic venous drainage in pancreas transplantation: a retrospective study. Ann. Surg. 234, 689–696 (2001).
Gruessner, A. C., Sutherland, D. E. R., & Gruessner, R. W. G. Long-term outcome after pancreas transplantation. Curr. Opin. Organ. Transplant. 17, 100–105 (2012).
Muthusamy, A. S., Mumford, L., Hudson, A, Fuggle, S. V. & Friend, P. J. Pancreas transplantation from donors after circulatory death from the United Kingdom. Am. J. Transplant. 12, 2150–2156 (2012).
Sutherland, D. E. R., Najarian, J. S. & Gruessner, R. W. G. in Living Donor Organ Transplantation (eds Gruessner, R. W. G. & Benedetti, E.) Section II. 18, 369–437 (McGraw-Hill Companies, 2008).
Smets, Y. F. C. et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type 1 diabetes mellitus and end-stage renal failure. Lancet 253, 1915–1919 (1999).
Becker, B. N. et al. Simultaneous pancreas-kidney transplantation reduces excess mortality in type-1 diabetic patients with end-stage renal disease. Kidney Int. 57, 2129–2135 (2000).
Ojo, A. O. et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 71, 82–90 (2001).
Reddy, K. S. et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am. J. Kidney Dis. 41, 464–470 (2003).
Kleinclauss, F. et al. Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin. Transplant. 23, 437–446 (2009).
Gruessner, R. W. G., Sutherland, D. E. R. & Gruessner, A. C. Mortality assessment for pancreas transplants. Am. J. Transplant. 4, 2018–2026 (2004).
Venstrom, J. M. et al. Survival after pancreas transplant in patients with diabetes and preserved kidney function. JAMA 290, 2817–2823 (2003).
Fioretto, P., Steffes, M. W., Sutherland, D. E. R., Goetz, F. C. & Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N. Engl. J. Med. 339, 69–75 (1998).
Fiorina, P. et al. Altered kidney graft high-energy phosphate metabolism in kidney-transplanted end-stage renal disease type 1 diabetic patients: a cross-sectional analysis of the effect of kidney along and kidney-pancreas transplantation. Diabetes Care 30, 597–603 (2007).
Fioretto, P., Sutherland, D. E. R., Najafian, B. & Mauer, M. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 69, 907–912 (2006).
Kennedy, W. R., Navarro, X., Goetz, F. C., Sutherland, D. E. R. & Najarian, J. S. Effects of pancreatic transplantation on diabetic neuropathy. N. Engl. J. Med. 322, 1031–1037 (1990).
Navarro, X., Sutherland, D. E. R. & Kennedy, W. R. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann. Neurol. 42, 727–736 (1997).
Martinenghi, S. et al. Amelioration of nerve conduction velocity following simultaneous kidney/pancreas transplantation is due to the glycemic control provided by the pancreas. Diabetologia 40, 1110–1112 (1997).
Gaber, A. O. et al. Changes in gastric emptying in recipients of successful combined pancreas-kidney transplants. Dig. Dis. 9, 437–443 (1991).
Giannarelli, R. et al. Effects of pancreas-kidney transplantation on diabetic retinopathy. Transpl. Int. 18, 619–622 (2005).
Koznarova, R. et al. Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant. 9, 903–908 (2000).
Morrissey, P. E., Shaffer, D., Monaco, A. P., Conway, P. & Madras, P. N. Peripheral vascular disease after kidney-pancreas transplantation in diabetic patients with end-stage renal disease. Arch. Surg. 132, 358–361 (1997).
Beisenbach, G., Konigsrainer, A., Gross, C. & Margreiter, R. Progression of macrovascular diseases is reduced in type 1 diabetic patients after more than 5 years successful combined pancreas-kidney transplantation in comparison to kidney transplantation alone. Transpl. Int. 18, 1054–1060 (2005).
Senior, P. A. et al. Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates. Diabetes Care 28, 866–872 (2005).
La Rocca, E. et al. Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int. 60, 1964–1971 (2001).
Gaber, A. O. et al. Early improvement in cardiac function occurs for pancreas-kidney but not diabetic kidney-alone transplant recipients. Transplantation 59, 1105–1112 (1995).
Larsen, J. L. et al. Pancreas transplantation improves vascular disease in patients with type 1 diabetes. Diabetes Care 27, 1706–1711 (2004).
Larsen, J. L. et al. Carotid intima-media thickness decreases after pancreas transplantation. Transplantation 73, 936–940 (2002).
La Rocca, E. et al. Evolution of carotid vascular lesions in kidney-pancreas and kidney-alone transplanted insulin-dependent diabetic patients. Transplant. Proc. 27, 3072 (1995).
Fiorina, P. et al. Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 23, 1804–1810 (2000).
Fioretto, P. & Mauer, M. Reversal of diabetic nephropathy: lessons from pancreas transplantation. J. Nephrol. 25, 13–18 (2012).
Giannarelli, R. et al. Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients. Diabetologia 49, 2977–2982 (2006).
Coppelli, A. et al. Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 76, 974–976 (2003).
Jukema, J. W. et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 25, 906–911 (2002).
Folli, F. et al. Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients' skin which are normalized by kidney-pancreas transplantation. PLoS ONE 5, e9923 (2010).
Salonia, A. et al. Kidney-pancreas transplantation is associated with near-normal sexual function in uremic type 1 diabetic patients. Transplantation 92, 802–808 (2011).
Fiorina, P. et al. Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantation. Diabetes Care 35, 367–374 (2012).
Ramsay, R. C. et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N. Engl. J. Med. 318, 208–214 (1988).
Robertson, R. P. Pancreas and islet transplants for patients with diabetes: taking positions and making decisions. Endocr. Pract. 5, 24–28 (1999).
Dieterle, C. D., Arbogast, H, Illner, W. D., Schmauss, S. & Landgraf, R. Metabolic follow-up after long-term pancreas graft survival. Eur. J. Endocrinol. 156, 603–610 (2007).
Rickels, M. R. Recovery of endocrine function after islet and pancreas transplantation. Curr. Diab. Rep. 12, 587–596 (2012).
Lauria, M. W. et al. The impact of functioning pancreas-kidney transplantation and pancreas alone transplantation on the lipid metabolism of statin-naive diabetic patients. Clin. Transplant. 23, 199–205 (2009).
Larsen, J. et al. Lipid status after combined pancreas-kidney transplantation and kidney transplantation alone in type 1 diabetes mellitus. Transplantation 54, 992–996 (1992).
Nakache, R., Tyden, G. & Groth, C. G. Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes 38 (Suppl. 1), S40–S42 (1989).
Zehrer, C. & Gross, C. Quality of life in pancreas transplant recipients. Diabetologia 34 (Suppl. 1), S145–S149 (1991).
Gross, C. R. & Zehrer, C. L. Health-related quality of life of outcomes of pancreas transplant recipients. Clin. Transplant. 6, 165–171 (1992).
Zehrer, C. L. & Gross, C. R. Prevalence of “low blood glucose” symptoms and quality of life in pancreas transplant recipients. Clin. Transplant 7, 312–319 (1993).
Milde, F. K., Hart, L. K. & Zehr, P. S. Pancreatic transplantation: impact on the quality of life in diabetic renal transplant recipients. Diabetes Care 18, 93–95 (1995).
Matas, A. J. Long-term quality of life after kidney and simultaneous pancreas-kidney transplantation. Clin. Transplant. 12, 233–242 (1998).
Shapiro, A. M. et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N. Eng. J. Med. 343, 230–238 (2000).
Shapiro, A. M. et al. International trial of the Edmonton protocol for islet transplantation. N. Engl. J. Med. 355, 1318–3130 (2006).
Hering, B. J. Achieving and maintaining insulin independence in human islet transplant recipients. Transplantation 79, 1296–1297 (2005).
Shapiro, A. M., Ricordi, C. & Hering, B. J. Edmonton's islet success has indeed been replicated elsewhere. Lancet 362, 1242 (2003).
Fiorina, P., Shapiro, A. M., Ricordi, C. & Secchi, A. The clinical impact of islet transplantation. Am. J. Transplant. 8, 1990–1997 (2008).
Barton, F. B. et al. Improvement in outcomes of clinical islet transplantation: 1999–2010. Diabetes Care. 35, 1436–1445 (2012).
Bellin, M. D. et al. Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes. Am. J. Transplant. 12, 1576–1583 (2012).
Rickels, M. R. et al. Islet cell hormonal responses to hypoglycemia after human islet transplantation for type 1 diabetes. Diabetes 54, 3205–3211 (2005).
Maffi, P. et al. Risks and benefits of transplantation in the cure of type 1 diabetes: whole pancreas versus islet transplantation. A single center study. Rev. Diabet. Stud. 8, 44–50 (2011).
The authors would like to thank M. Knatterud and J. Roberts from the Department of Surgery at the University of Arizona, USA, for their help with preparing the manuscript.
The authors declare no competing financial interests.
About this article
Cite this article
Gruessner, R., Gruessner, A. The current state of pancreas transplantation. Nat Rev Endocrinol 9, 555–562 (2013). https://doi.org/10.1038/nrendo.2013.138
This article is cited by
Die Diabetologie (2022)
Nature Reviews Endocrinology (2021)
Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives
Reviews in Endocrine and Metabolic Disorders (2021)
Human umbilical cord mesenchymal stem cells in type 2 diabetes mellitus: the emerging therapeutic approach
Cell and Tissue Research (2021)
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)